2.Immunophenotypic and Clinical Characteristics of SET-CAN Fusion Gene Positive Acute Leukemia Patients.
Song-Ya LIU ; Li ZHU ; Chun-Yan WANG ; Cheng HE ; Shu-Juan YI ; Li MENG ; Min XIAO ; Xia MAO
Journal of Experimental Hematology 2023;31(6):1639-1646
OBJECTIVE:
To analyze the flow immunophenotype and clinical characteristics of leukemia patients with positive SET-CAN fusion gene.
METHODS:
A total of 7 newly diagnosed acute leukemia patients with SET-CAN fusion gene admitted to Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology from February 2016 to February 2020 were collected. Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the expression of SET-CAN fusion gene. The immunophenotype was detected by four-color flow cytometry. The case information of 17 literatures published at home and abroad was extracted for statistical analysis.
RESULTS:
Among the 7 patients, 2 cases were diagnosed as mixed phenotype acute leukemia (MPAL), 2 cases as acute myeloid leukemia (AML), and 3 cases as T-acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL). Leukemia cells in bone marrow specimens of all cases expressed or partially expressed CD34, CD33 and CD7. CD5 and cytoplasmic CD3 were expressed in 5 patients except 2 patients diagnosed with AML. Bone marrow and lymph node specimens were both detected in 2 patients, and the immunophenotypes of the two specimens were not completely consistent, with differences in lineage or maturity related markers. Two patients with MPAL showed differentiated response to treatment. One AML patient gave up treatment, and another AML patient with FLT3-ITD gene mutation had a poor prognosis. All three T-ALL/LBL patients maintained a long duration of remission after induced remission, and one case underwent allogeneic hematopoietic stem cell transplantation.
CONCLUSIONS
There are common characteristics of immunophenotype in patients with positive SET-CAN fusion gene. Differential expression of immunophenotype in samples from different parts is observed in some cases. The prognosis of these diseases varies.
Humans
;
Leukemia, Myeloid, Acute/pathology*
;
Bone Marrow/pathology*
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics*
;
Antigens, CD34
;
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
;
Immunophenotyping
3.Clinicopathologic features and prognosis of T lymphoblastic lymphoma associated with Langerhans cell histiocytosis.
Xinxia LI ; Ye WANG ; Rong CHEN ; Dilinazi ABULAITI ; Zhiping MA ; Na MIAO ; Gulinaer ABULAJIANG ; Wei ZHANG
Chinese Journal of Pathology 2014;43(8):522-527
OBJECTIVETo study the clinicopathologic features, immunophenotype and molecular genetic changes of T lymphoblastic lymphoma (T-LBL) associated with Langerhans cell histiocytosis (LCH).
METHODSThree cases of T-LBL associated with LCH were included. The morphologic characteristics were reviewed along with immunohistochemical profiling using EnVision method and TCR gene rearrangement by PCR. A review of composite lymphoma previously reported in the literature was performed.
RESULTSAll three patients were male with the mean age of 61.7 years. One was Hans and the other 2 were Uyguers. All presented with superficial lymph node enlargement. Biopsy of lymph node showed two abnormal cell populations: distended sinus by large, pale histiocytes with nuclear grooves, and the interfollicular region containing immature-appearing cells with irregular nuclei slightly larger than that of small lymphocyte, dispersed chromatin, inconspicuous nucleoli, scant cytoplasm, and scattered mitotic figures. These cells presented in aggregates and small sheets interspersed with normal-appearing lymphocyte. The histiocytes were positive for CD1a, S-100 protein and CD68. The lymphoma cells were positive for CD3, CD7, TdT and CD34. TCR-γ gene rearrangement was detected in one case by PCR technology. One case involved bone marrow with double phenotype acute leukemia. Amongst the 8 including 5 reported cases, there were 4 males and 4 females. The mean age of the patients and the median age were 54 years. Lymphoadenopathy was the most common presentation. Bone marrow was involved in 4 cases. The time of follow-up was 2 to 27 months. The median survival was 5.5 months and the one-year survival rate was 33.3%.
CONCLUSIONSDiagnosis of T-LBL and LCH should be based on typical morphology, immunophenotype and molecular genetic findings, with differential diagnoses including Langerhans cell hyperplasia originated from dermatopathic lymphadenopathy. When involving lymph node, extensive sampling supplemented by immunohistochemical staining is important to reach a correct diagnosis. Although coexistent T-LBL and LCH is clonally related, the understanding of its pathogenesis requires further investigation.
Bone Marrow ; pathology ; Female ; Gene Rearrangement ; Histiocytosis, Langerhans-Cell ; genetics ; pathology ; Humans ; Immunophenotyping ; Leukemia ; genetics ; Lymph Nodes ; pathology ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; genetics ; pathology ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ; genetics ; pathology ; Prognosis
4.Detection of microvesicle miRNA expression in ALL subtypes and analysis of their functional roles.
Wen-Ying LI ; Xiao-Mei CHEN ; Wei XIONG ; Dong-Mei GUO ; Li LU ; Hui-Yu LI
Journal of Huazhong University of Science and Technology (Medical Sciences) 2014;34(5):640-645
Microvesicles (MVs) are the heterogeneous mixtures of vesicles. MVs released by leukemia cells constitute an important part of the leukemia microenvironment. MVs might act as important reservoirs of microRNAs (miRNAs). It is worth evaluating whether MVs possess some unique miRNA contents that are valuable in understanding the pathogenesis. In this study, we investigated the miRNA expression patterns of Nalm-6-derived MVs, Jurkat-derived MVs and normal cell-derived MVs using miRNA microarrays. The potential target genes regulated by differentially expressed miRNAs were also predicted and analyzed. Results demonstrated that 182 miRNAs and 166 miRNAs were differentially expressed in Nalm-6-MVs and Jurkat-MVs, respectively. Many oncogenes, tumor suppressors and signal pathway genes were targeted by these aberrantly expressed miRNAs, which might contribute to the development of B-ALL or T-ALL. Our findings expanded the potential diagnostic markers of ALL and provided useful information for ALL pathogenesis.
Gene Expression Profiling
;
Gene Expression Regulation, Leukemic
;
Humans
;
Jurkat Cells
;
MicroRNAs
;
genetics
;
Multivesicular Bodies
;
genetics
;
Oligonucleotide Array Sequence Analysis
;
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
;
genetics
;
pathology
;
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
;
genetics
;
pathology
;
Reverse Transcriptase Polymerase Chain Reaction
5.ALL-XH-99 protocol in the treatment of childhood T-cell acute lymphoblastic leukemia.
Qi-dong YE ; Long-jun GU ; Jing-yan TANG ; Hui-liang XUE ; Jing CHEN ; Ci PAN ; Jing CHEN ; Lu DONG ; Min ZHOU
Chinese Journal of Hematology 2009;30(1):26-28
OBJECTIVETo analyze the incidence, clinical characteristics and prognosis of childhood T-cell acute lymphoblastic leukemia (T-ALL).
METHODSFrom January 1999 to April 2005, 305 patients with newly diagnosed ALL were enrolled in protocol ALL-XH-99. The clinical characteristics of these children were analysed.
RESULTSOf 305 childhood ALL patients, 43 were T-ALL. There were 34 males among the 43 T-ALLs. The mean age at diagnosis was 7.8 (2.2 to 16.4) years, 29 (67.4%) cases of them were older than 10 years, and 27 (62.8%) cases had initial WBC count more than 50 x 10(9)/L. In comparison with that of B cell ALL (B-ALL), the percentages of age older than 10 years, initial WBC count more than 50 x 10(9)/ L, prednisone poor response (PPR), and failed to achieve remission at day 19 of induction chemotherapy in the T-ALLs were all higher. No statistic difference was found in sex between them. The eight-year event-free survival (EFS), relapse-free survival (RFS) and overall survival (OS) were (40.2 +/- 10.1)%, (51.4 +/- 11.6)% and (49.8 +/- 9.9)% for T-ALL, and (72.1-3.0)%, (83.2 +/- 2.7)%, and (76.6 +/- 2.9)% for B-ALL, respectively, being differed significantly between the two types of ALL (P < 0.01).
CONCLUSIONThere were statistic differences between T-cell and B-cell childhood ALLs in age, initial WBC count, early response to therapy, and eight-year EFS and RFS. Childhood T-ALL was associated with a worse prognosis than other sub-types of childhood ALL.
Adolescent ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Humans ; Immunophenotyping ; Infant ; Karyotyping ; Male ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma ; genetics ; immunology ; pathology ; therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ; genetics ; immunology ; pathology ; therapy ; Prognosis
6.Advances in blastic plasmacytoid dendritic cell neoplasm.
Chinese Journal of Pathology 2013;42(2):131-134
CD4 Antigens
;
metabolism
;
CD56 Antigen
;
metabolism
;
Dendritic Cells
;
pathology
;
Diagnosis, Differential
;
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
;
Hematologic Neoplasms
;
drug therapy
;
genetics
;
metabolism
;
pathology
;
surgery
;
Humans
;
Immunohistochemistry
;
Leukemia, Myeloid
;
pathology
;
Lymphoma, Extranodal NK-T-Cell
;
pathology
;
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
;
pathology
;
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
;
pathology
;
Skin Neoplasms
;
drug therapy
;
genetics
;
metabolism
;
pathology
;
surgery
7.Immunophenotyping of leukemic stem cells and chromosome karyotype characteristics in Uyghur leukemia pediatric patients.
Nuriding HAILIQIGULI ; Mei YAN
Chinese Journal of Oncology 2013;35(7):501-504
OBJECTIVETo study the immunophenotype and chromosome karyotype characteristics of leukemic stem cells (LSC) in Uyghur leukemia pediatric patients.
METHODSThe morphological features of LSC in culture in vitro was observed by flow cytometry. The immunophenotype was assessed by detective flow cytometry. The chromosome karyotype was analyzed by R-banding technique.
RESULTSThe LSC showed suspended floating colonies growing in the culture medium, and grew well and proliferated constantly in culture over 8 months. Among the 13 children with AML, there were 10 CD34(+)CD38(-)CD123(+) and CD33(+) cases, 10 CD44(+) cases, 10 CD96(+) cases, and 5 CD90(+) cases. Among the 13 children with B-ALL, there were 6 CD34(+)CD20(-)CD19(+) cases, 7 CD9(+) cases, and 5 CD123(+) cases. Among the 9 children with acute T lymphoblastic leukemia (T-ALL), there were 5 CD34(+)CD7(-) and CD90(+) cases, and 4 CD123(+) cases. Among the 13 cases of AML, 5 cases showed chromosome translocation t(15;17), one case chromosome translocation t(8;21), and 7 cases showed no chromosome karyotype abnormality. Among the 22 ALL cases, there were chromosome translocation t(12;21) in 1 case, t(9;22) in 3 case, hyperdiploid in 2 cases, and 16 cases without karyotype abnormalities. Twenty-nine children received induction remission therapy. Among them, 12 died, including 9 CD96(-)positive cases and 3 CD96(-)negative cases, with a statistically significant difference (P < 0.05).
CONCLUSIONSThe LSC of Uyghur leukemia pediatric patients in Xinjiang express CD9 and CD19 in ALL, and express CD123 and CD90 simultaneously in ALL and AML. The expression of CD96 is one of factors of poor prognosis.
Adolescent ; Antigens, CD ; metabolism ; Antigens, CD19 ; metabolism ; Child ; China ; ethnology ; Diploidy ; Humans ; Immunophenotyping ; Interleukin-3 Receptor alpha Subunit ; metabolism ; Karyotyping ; Leukemia, Myeloid, Acute ; drug therapy ; genetics ; immunology ; pathology ; Neoplastic Stem Cells ; immunology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; drug therapy ; genetics ; immunology ; pathology ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ; drug therapy ; genetics ; immunology ; pathology ; Remission Induction ; Tetraspanin-29 ; metabolism ; Thy-1 Antigens ; metabolism ; Translocation, Genetic
8.Simultaneous Translocation of Both TCR Loci (14q11) with Rare Partner Loci (Xq22 and 12p13) in a Case of T-lymphoblastic Leukemia.
Dong Hee KANG ; Se Hyung KIM ; Jeong Woo JUN ; Yong Wha LEE ; Hee Bong SHIN ; Jee Young AHN ; Dae Sik HONG ; You Kyoung LEE ; Byung Ryul JEON
Annals of Laboratory Medicine 2012;32(3):220-224
The most common recurrent cytogenetic abnormalities in T-lymphoblastic leukemia (T-acute lymphoblastic leukemia [T-ALL]) involve T-cell receptor (TCR) loci and a variety of partner genes, including HOX11, HOX11L2, MYC, and TAL1. In this report, we present a rare case involving simultaneous translocation of the TCR alpha/delta loci with different partner loci (Xq22 and 12p13); this resulted in a poor prognosis. Chromosomal analysis showed 46,Y,t(X;14)(q22;q11.2),t(12;14)(p13;q11.2) and FISH analysis by using a T-cell receptor alpha delta DNA probe, Split Signal (DakoCytomation, Denmark), showed translocations at the same TCR alpha/delta locus on both chromosomes. FISH with 2 bacterial artificial chromosome clones showed break apart signal, which suggests involvement of the IRS4 gene. To our knowledge, this is the first report of T-ALL in which both TCR alpha/delta loci were translocated with different partner loci, and 1 of the partner loci, Xq22, was a rare translocation partner locus that included IRS4 gene.
Adult
;
Chromosomes, Human, Pair 12
;
Chromosomes, Human, Pair 14
;
Chromosomes, Human, X
;
Genetic Loci
;
Humans
;
Insulin Receptor Substrate Proteins/genetics
;
Karyotyping
;
Male
;
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*genetics/pathology
;
Receptors, Antigen, T-Cell/*genetics
;
*Translocation, Genetic
9.Advances of lymphoblastic lymphoma and its molecular genetics.
Yun PAN ; Gan-di LI ; Wei-ping LIU
Chinese Journal of Pathology 2005;34(4):236-239
Basic Helix-Loop-Helix Transcription Factors
;
metabolism
;
Chromosome Aberrations
;
DNA Nucleotidylexotransferase
;
metabolism
;
Humans
;
Immunoglobulin Light Chains
;
metabolism
;
Immunoglobulin Light Chains, Surrogate
;
Lymphoma, B-Cell
;
genetics
;
metabolism
;
pathology
;
Lymphoma, T-Cell
;
genetics
;
metabolism
;
pathology
;
Membrane Glycoproteins
;
metabolism
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
genetics
;
metabolism
;
pathology
;
Proto-Oncogene Proteins
;
metabolism
;
T-Cell Acute Lymphocytic Leukemia Protein 1
10.Establishment of a real time quantitative-PCR assay for detection of TCR VgammaI-Jgamma gene rearrangement in acute lymphoblastic leukemia patients.
Xiao-gong JIANG ; Bing XU ; Wen-juan XU ; Bing LI
Chinese Journal of Hematology 2004;25(7):425-428
OBJECTIVETo improve the techniques for minimal residual disease (MRD) detection in acute lymphoblastic leukemia (ALL).
METHODSA real time quantitative PCR method was established for quantifying the clonal TCRVgammaI-Jgamma gene rearrangement in 36 ALL patients.
RESULTSThe sensitivity of the established real time quantitative PCR was at 10(-4) level. The amount of TCRVgammaI-Jgamma gene rearrangement in newly diagnosed group, complete remission (CR) group and post hematopoietic stem cell transplantation (HSCT) group was (7.38 +/- 6.65) x 10(-2), (1.02 +/- 1.08) x 10(-2) and (3.89 +/- 5.65) x 10(-3) level, respectively. and the amount in newly diagnosed group was higher than that in CR group and HSCT group (P = 0.001). The MRD level of ALL patients in CR group was higher than that in HSCT group (P = 0.022). MRD can be detected in 6 ALL patients after HSCT, 2 of them with low MRD level (< 1 x 10(-3)) survived long disease-free survival, the other 4 with high MRD level relapsed within one year.
CONCLUSIONThe established real time quantitative PCR assay is simple, rapid, sensitive and specific. Use of this assay to evaluate MRD in the remission ALL cases is helpful for prognosis prediction.
Adolescent ; Adult ; Female ; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor ; genetics ; Humans ; Immunoglobulin Variable Region ; genetics ; Male ; Polymerase Chain Reaction ; methods ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; genetics ; pathology ; therapy ; Prognosis ; Reproducibility of Results